 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE28878 |
Liver Cancer |
Expression Profiles of HepG2 cells treated with genotoxic and non-genotoxic agents |
2011 |
Tissue |
N |
560 |
 |
|
GSE45436 |
Liver Cancer |
Gene expression profiles of human hepatocellular carcinoma |
2013 |
Tissue |
N |
134 |
|
|
GSE62232 |
Liver Cancer |
Large-scale gene expression profiling of 81 hepatocellular carcinomas |
2014 |
Tissue |
N |
91 |
|
|
GSE65484 |
Liver Cancer |
aCGH profiling for Frozen tumour samples of 50 Hepatocellular Carcinoma patients and 14 Adjacent normal samples |
2015 |
Tissue |
N |
64 |
|
|
GSE75271 |
Liver Cancer |
mRNA profiles of 50 HB tumors |
2015 |
Tissue |
N |
55 |
|
|
GSE41804 |
Liver Cancer |
Hepatic gene expression of HCV related Hepatocellular carcinoma and non-cancerous tissue with Il28B rs8099917 TT genotype and TG/GG genotype |
2012 |
Tissue |
N |
40 |
|
|
GSE79850 |
Cholangitis |
Digital expression profiling highlights a distinct live RNA signature in high-risk Primary Biliary Cholangitis (PBC) |
2016 |
Tissue |
N |
24 |
 |
|
GSE29721 |
Liver Cancer |
The landscape of promoter DNA hypomethylation in liver cancer (expression data) |
2011 |
Tissue |
N |
20 |
|
|
E-MTAB-10646 |
Liver cell |
Liver cell lines under hyper-IL6 stimulation (mRNA) |
2021 |
Tissue |
N |
20 |
|
|
|
|
|
|
|
|
|